Solvent Extraction · Founded 1991 · www.ambujagroup.com · BSE 524226 · NSE GUJ AMB EXP · ISIN INE036B01030
No Notes Added Yet
Business
Gujarat Ambuja Exports Ltd. (GAEL) is a leading Indian agro-processing company with a diversified portfolio. Its core business involves processing various agricultural commodities to produce a range of products for food, feed, and industrial applications. GAEL operates across several key segments:
Solvent Extraction: Processing oilseeds (such as soybean, mustard, castor, groundnut) to extract crude edible oils and produce de-oiled cakes (DOC) which are primarily used as animal feed.
Edible Oil Refining: Refining crude oils into refined edible oils for human consumption, often sold under its own brands or to other distributors.
Maize Products: Manufacturing a variety of maize-based derivatives including maize starch, liquid glucose, dextrose monohydrate, sorbitol, and other specialty starches and sweeteners for food, pharmaceutical, and industrial sectors.
Cotton Ginning: Processing raw cotton to separate lint from seeds.
Feed Ingredients: Producing various animal feed products for poultry, aquaculture, and livestock, utilizing de-oiled cakes and other by-products.
The company makes money through the sale of these processed agro-commodities in both domestic and international markets, capitalizing on value addition at various stages of the agricultural value chain.
Revenue Mix
GAEL's revenue mix is primarily driven by its two largest segments:
Maize Products: Historically, this segment contributes a significant portion of the total revenue, often ranging from 35-45%.
Edible Oil & Solvent Extraction: This combined segment also forms a substantial part of the revenue, typically in the range of 30-40%.
Feed Ingredients: This segment contributes a smaller but growing portion.
Cotton Ginning: This segment's contribution is generally smaller and more seasonal.
(Specific current percentages are not publicly available without direct financial report access, but these represent the general proportions.)
Industry
GAEL operates in the highly competitive Indian agro-processing sector.
Solvent Extraction & Edible Oils: India is a major consumer and net importer of edible oils. The industry is characterized by a mix of large integrated players (like Adani Wilmar, Patanjali Foods) and numerous regional processors. GAEL is a significant and established player, particularly in Western India, with a strong focus on both domestic sales and exports of de-oiled cakes.
Maize Products: This is a growing industry driven by demand from the food, pharmaceutical, and textile sectors. GAEL is one of the larger and more diversified players in maize processing in India, competing with companies like Sukhjit Starch & Chemicals and Anil Ltd., offering a broad range of derivatives.
The company's diversified presence across multiple agri-processing value chains helps mitigate risks associated with reliance on a single commodity.
MOAT
GAEL possesses several competitive advantages:
Diversified & Integrated Operations: Its presence across multiple agri-commodities (oilseeds, maize, cotton) and integrated value chains (from extraction to refined oils, feed, and derivatives) provides economies of scale, operational synergies, and reduces reliance on a single product or market.
Significant Scale & Capacity: GAEL has substantial processing capacities across its various segments, allowing for cost efficiencies and the ability to cater to large orders.
Established Market Presence & Distribution: Decades of operation have built strong relationships with suppliers and customers, along with an established distribution network for its products both domestically and internationally (especially for DOC exports).
Commodity Risk Management: Experience in managing the inherent volatility of agricultural commodity prices through hedging and inventory management strategies.
Growth Drivers
Rising Demand for Food & Feed: India's growing population, increasing disposable incomes, urbanization, and changing dietary patterns will continue to drive demand for edible oils, maize derivatives (in food & beverages), and animal feed products.
Capacity Expansions: Strategic investments in enhancing processing capacities across key segments (especially maize and edible oils) will enable GAEL to capture a larger market share.
Diversification into Value-Added Products: Focus on developing and marketing higher-value-added maize derivatives and specialty ingredients can improve margin profiles.
Export Opportunities: Continued global demand for de-oiled cakes (animal feed) and other agri-products presents export growth avenues.
Government Focus on Food Processing: Supportive government policies and initiatives for the food processing sector could create a favorable operating environment.
Risks
Commodity Price Volatility: Prices of raw materials (oilseeds, maize, cotton) and finished products are subject to significant fluctuations due to global supply-demand dynamics, weather patterns, and geopolitical events, directly impacting profitability.
Monsoon and Weather Dependency: Agricultural output in India is highly dependent on the monsoon, affecting the availability and pricing of key raw materials.
Regulatory & Trade Policy Changes: Changes in government policies regarding import duties, export incentives, minimum support prices, and other trade regulations for agri-commodities can significantly impact the business.
Intense Competition: The sectors GAEL operates in, especially edible oils and basic starches, are highly competitive, potentially leading to margin pressure.
Foreign Exchange Fluctuations: As an exporter and importer of commodities, GAEL is exposed to currency fluctuation risks.
Supply Chain Disruptions: Geopolitical events, pandemics, or logistical bottlenecks can disrupt raw material sourcing and product distribution.
Management & Ownership
GAEL is promoted by the Patel family. The company has a professional management team with significant experience in the agro-processing industry. The promoter group holds a substantial majority stake in the company, which indicates strong alignment of interests between the promoters and the company's long-term performance. The management has historically focused on sustainable growth and financial prudence.
Outlook
GAEL is well-positioned in the growing Indian agro-processing sector due to its diversified business model, integrated operations, and significant scale. The increasing demand for food, feed, and industrial ingredients in India provides a strong underlying growth narrative. The company's focus on capacity expansion and potentially higher-value-added products could drive future revenue and profitability.
However, the business remains inherently exposed to the volatility of agricultural commodity prices, which can impact margins. Dependence on monsoon and potential adverse government policy changes regarding trade and agriculture pose ongoing risks. Competition in its key segments is also intense. A balanced outlook suggests GAEL's established presence and strategic diversification offer resilience, but its performance will continue to be closely linked to commodity cycles and the broader agricultural landscape.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 1302 | 1346 | 1090 | 1125 | 1131 | 1267 | 1291 | 1487 | 1484 | 1467 |
| Other Income | 39 | 37 | 29 | 20 | 9 | 25 | 30 | 19 | 32 | 25 |
| Total Income | 1340 | 1384 | 1119 | 1144 | 1140 | 1292 | 1322 | 1506 | 1517 | 1492 |
| Total Expenditure | 1176 | 1235 | 985 | 1015 | 1008 | 1204 | 1195 | 1411 | 1385 | 1272 |
| Operating Profit | 164 | 149 | 135 | 130 | 132 | 87 | 127 | 95 | 132 | 220 |
| Interest | 3 | 3 | 3 | 4 | 3 | 6 | 5 | 9 | 6 | 7 |
| Depreciation | 30 | 30 | 31 | 31 | 32 | 32 | 35 | 35 | 33 | 34 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5 | 1 |
| Profit Before Tax | 131 | 115 | 100 | 94 | 97 | 49 | 86 | 51 | 88 | 180 |
| Provision for Tax | 30 | 24 | 24 | 25 | 26 | 17 | 21 | 13 | 22 | 44 |
| Profit After Tax | 101 | 91 | 77 | 69 | 71 | 32 | 65 | 38 | 66 | 135 |
| Adjustments | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 101 | 91 | 77 | 69 | 71 | 32 | 65 | 38 | 66 | 135 |
| Adjusted Earnings Per Share | 2.2 | 2 | 1.7 | 1.5 | 1.6 | 0.7 | 1.4 | 0.8 | 1.4 | 3 |
| #(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 2122 | 3016 | 3092 | 2531 | 2736 | 3817 | 4705 | 4670 | 4909 | 4927 | 4613 | 5729 |
| Other Income | 5 | 15 | 15 | 11 | 14 | 10 | 29 | 54 | 74 | 145 | 82 | 106 |
| Total Income | 2127 | 3030 | 3106 | 2542 | 2751 | 3826 | 4734 | 4724 | 4983 | 5071 | 4695 | 5837 |
| Total Expenditure | 2016 | 2827 | 2902 | 2368 | 2553 | 3535 | 4173 | 3983 | 4434 | 4484 | 4212 | 5263 |
| Operating Profit | 112 | 204 | 205 | 174 | 198 | 291 | 561 | 741 | 549 | 587 | 483 | 574 |
| Interest | 21 | 22 | 21 | 15 | 10 | 9 | 6 | 6 | 13 | 18 | 17 | 27 |
| Depreciation | 30 | 37 | 47 | 61 | 65 | 101 | 103 | 97 | 95 | 121 | 126 | 137 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4 |
| Profit Before Tax | 61 | 145 | 137 | 98 | 123 | 181 | 452 | 638 | 441 | 448 | 341 | 405 |
| Provision for Tax | 11 | 32 | 25 | 14 | 19 | 36 | 114 | 163 | 111 | 102 | 92 | 100 |
| Profit After Tax | 50 | 113 | 111 | 84 | 104 | 146 | 338 | 475 | 330 | 346 | 249 | 304 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 |
| Profit After Adjustments | 50 | 113 | 111 | 84 | 104 | 146 | 338 | 475 | 330 | 346 | 249 | 304 |
| Adjusted Earnings Per Share | 0.9 | 2 | 2 | 1.5 | 1.9 | 3.2 | 7.4 | 10.4 | 7.2 | 7.5 | 5.4 | 6.6 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -6% | -0% | 4% | 8% |
| Operating Profit CAGR | -18% | -13% | 11% | 16% |
| PAT CAGR | -28% | -19% | 11% | 17% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 41% | 12% | 14% | 28% |
| ROE Average | 9% | 12% | 17% | 15% |
| ROCE Average | 12% | 15% | 21% | 17% |
| #(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 556 | 656 | 756 | 827 | 916 | 1326 | 1657 | 2118 | 2434 | 2769 | 3002 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5 | 0 |
| Borrowings | 3 | 0 | 0 | 25 | 22 | 1 | 2 | 3 | 3 | 2 | 3 |
| Other Non-Current Liabilities | 50 | 59 | 54 | 59 | 60 | 58 | 64 | 71 | 75 | 95 | 125 |
| Total Current Liabilities | 531 | 488 | 501 | 374 | 423 | 350 | 440 | 561 | 440 | 439 | 458 |
| Total Liabilities | 1140 | 1203 | 1312 | 1284 | 1421 | 1736 | 2163 | 2753 | 2952 | 3310 | 3587 |
| Fixed Assets | 289 | 458 | 479 | 543 | 562 | 787 | 731 | 771 | 1042 | 1037 | 1179 |
| Other Non-Current Assets | 240 | 109 | 144 | 141 | 178 | 51 | 168 | 343 | 197 | 388 | 470 |
| Total Current Assets | 610 | 635 | 688 | 601 | 681 | 896 | 1263 | 1637 | 1708 | 1882 | 1936 |
| Total Assets | 1140 | 1203 | 1312 | 1284 | 1421 | 1736 | 2163 | 2753 | 2952 | 3310 | 3587 |
| #(Fig in Cr.) | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 8 | 6 | 6 | 6 | 6 | 10 | 94 | 92 | 11 | 104 | 9 |
| Cash Flow from Operating Activities | -4 | 294 | -120 | 253 | 135 | 241 | 297 | 596 | 241 | 213 | 341 |
| Cash Flow from Investing Activities | -95 | -79 | -73 | -130 | -130 | -60 | -302 | -777 | -72 | -253 | -336 |
| Cash Flow from Financing Activities | 96 | -209 | 187 | -124 | -3 | -97 | 2 | 100 | -76 | -55 | -13 |
| Net Cash Inflow / Outflow | -2 | 6 | -6 | -0 | 2 | 84 | -3 | -81 | 93 | -95 | -8 |
| Closing Cash & Cash Equivalent | 6 | 12 | 6 | 6 | 8 | 94 | 92 | 11 | 104 | 9 | 1 |
| # | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.9 | 2.04 | 2.01 | 1.52 | 1.87 | 3.18 | 7.37 | 10.37 | 7.2 | 7.54 | 5.44 |
| CEPS(Rs) | 1.44 | 2.7 | 2.87 | 2.62 | 3.05 | 5.38 | 9.62 | 12.49 | 9.26 | 10.18 | 8.18 |
| DPS(Rs) | 0.15 | 0.2 | 0.18 | 0.21 | 0.2 | 0.25 | 0.3 | 0.33 | 0.35 | 0.35 | 0.25 |
| Book NAV/Share(Rs) | 10.05 | 11.85 | 13.67 | 14.95 | 16.56 | 28.92 | 36.12 | 46.19 | 53.07 | 60.37 | 65.45 |
| Core EBITDA Margin(%) | 4.96 | 6.21 | 6.08 | 6.35 | 6.62 | 7.37 | 11.31 | 14.67 | 9.67 | 8.97 | 8.68 |
| EBIT Margin(%) | 3.82 | 5.49 | 5.03 | 4.39 | 4.78 | 4.99 | 9.73 | 13.75 | 9.25 | 9.45 | 7.75 |
| Pre Tax Margin(%) | 2.84 | 4.78 | 4.37 | 3.8 | 4.42 | 4.74 | 9.61 | 13.63 | 8.98 | 9.07 | 7.38 |
| PAT Margin (%) | 2.34 | 3.71 | 3.56 | 3.28 | 3.73 | 3.82 | 7.18 | 10.15 | 6.72 | 7.01 | 5.4 |
| Cash Profit Margin (%) | 3.73 | 4.92 | 5.07 | 5.65 | 6.08 | 6.45 | 9.37 | 12.23 | 8.64 | 9.47 | 8.12 |
| ROA(%) | 4.68 | 9.63 | 8.86 | 6.48 | 7.66 | 9.24 | 17.34 | 19.34 | 11.57 | 11.05 | 7.23 |
| ROE(%) | 9.39 | 18.62 | 15.78 | 10.62 | 11.89 | 13 | 22.67 | 25.19 | 14.5 | 13.3 | 8.64 |
| ROCE(%) | 9.86 | 19 | 15.76 | 9.82 | 11.14 | 14.03 | 27.91 | 30.69 | 18.02 | 16.59 | 11.57 |
| Receivable days | 24.61 | 16.95 | 15.07 | 18.32 | 18.52 | 15.66 | 14.71 | 17.53 | 18.66 | 22.19 | 26.79 |
| Inventory Days | 62.82 | 49.77 | 55.65 | 66.88 | 57.48 | 49.15 | 51.24 | 54.16 | 49.44 | 53.68 | 59.64 |
| Payable days | 33.5 | 30.47 | 25.4 | 12.34 | 12.74 | 13.47 | 16.03 | 20.21 | 17.17 | 16.38 | 18.1 |
| PER(x) | 6.38 | 2.8 | 3.68 | 5.76 | 5.46 | 8.16 | 8.68 | 12.56 | 16.12 | 21.14 | 18.78 |
| Price/Book(x) | 0.57 | 0.48 | 0.54 | 0.59 | 0.62 | 0.9 | 1.77 | 2.82 | 2.19 | 2.64 | 1.56 |
| Dividend Yield(%) | 2.61 | 3.51 | 2.36 | 2.4 | 1.96 | 0.96 | 0.47 | 0.25 | 0.3 | 0.22 | 0.24 |
| EV/Net Sales(x) | 0.31 | 0.15 | 0.26 | 0.31 | 0.32 | 0.32 | 0.64 | 1.33 | 1.11 | 1.52 | 1.06 |
| EV/Core EBITDA(x) | 5.88 | 2.29 | 3.93 | 4.53 | 4.48 | 4.24 | 5.32 | 8.39 | 9.89 | 12.75 | 10.11 |
| Net Sales Growth(%) | 8.63 | 42.11 | 2.53 | -18.13 | 8.11 | 39.47 | 23.29 | -0.74 | 5.11 | 0.36 | -6.38 |
| EBIT Growth(%) | -37.59 | 104.34 | -5.68 | -28.4 | 17.75 | 43.74 | 140.24 | 40.53 | -29.43 | 2.54 | -23.24 |
| PAT Growth(%) | -46.44 | 126.05 | -1.25 | -24.52 | 23.26 | 40.7 | 131.81 | 40.63 | -30.57 | 4.78 | -27.94 |
| EPS Growth(%) | -46.44 | 126.05 | -1.25 | -24.52 | 23.26 | 69.79 | 131.81 | 40.63 | -30.57 | 4.75 | -27.91 |
| Debt/Equity(x) | 0.65 | 0.28 | 0.53 | 0.37 | 0.36 | 0.11 | 0.09 | 0.13 | 0.09 | 0.07 | 0.07 |
| Current Ratio(x) | 1.15 | 1.3 | 1.37 | 1.61 | 1.61 | 2.56 | 2.87 | 2.92 | 3.88 | 4.28 | 4.23 |
| Quick Ratio(x) | 0.45 | 0.37 | 0.38 | 0.42 | 0.59 | 0.85 | 1.22 | 1.73 | 2.37 | 2.49 | 2.65 |
| Interest Cover(x) | 3.9 | 7.68 | 7.62 | 7.51 | 13.39 | 20.38 | 79.41 | 113.35 | 34.27 | 25.35 | 21.37 |
| Total Debt/Mcap(x) | 1.13 | 0.58 | 0.98 | 0.64 | 0.58 | 0.12 | 0.05 | 0.05 | 0.04 | 0.03 | 0.05 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 63.84 | 63.84 | 63.84 | 63.84 | 63.84 | 63.84 | 63.84 | 63.84 | 63.84 | 63.84 |
| FII | 4.08 | 4.22 | 4.24 | 1.99 | 1.88 | 2.03 | 2.17 | 2.04 | 1.6 | 2.19 |
| DII | 1.15 | 2.36 | 1.39 | 0.63 | 0.39 | 0.51 | 0.19 | 0.61 | 0.58 | 0.83 |
| Public | 30.93 | 29.57 | 30.53 | 33.53 | 33.89 | 33.62 | 33.8 | 33.51 | 33.97 | 33.14 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 14.64 | 29.28 | 29.28 | 29.28 | 29.28 | 29.28 | 29.28 | 29.28 | 29.28 | 29.28 |
| FII | 0.94 | 1.94 | 1.94 | 0.91 | 0.86 | 0.93 | 0.99 | 0.94 | 0.74 | 1 |
| DII | 0.26 | 1.08 | 0.64 | 0.29 | 0.18 | 0.24 | 0.09 | 0.28 | 0.27 | 0.38 |
| Public | 7.09 | 13.56 | 14 | 15.38 | 15.54 | 15.42 | 15.5 | 15.37 | 15.58 | 15.2 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22.93 | 45.87 | 45.87 | 45.87 | 45.87 | 45.87 | 45.87 | 45.87 | 45.87 | 45.87 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -6% | 0% | +4% | +8% |
| Operating Profit CAGR | -18% | -13% | +11% | +16% |
| PAT CAGR | -28% | -19% | +11% | +17% |
| Share Price CAGR | +41% | +12% | +14% | +28% |
| ROE Average | +9% | +12% | +17% | +15% |
| ROCE Average | +12% | +15% | +21% | +17% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 63.84 | 63.84 | 63.84 | 63.84 | 63.84 | 63.84 | 63.84 | 63.84 | 63.84 | 63.84 |
| FII | 4.08 | 4.22 | 4.24 | 1.99 | 1.88 | 2.03 | 2.17 | 2.04 | 1.6 | 2.19 |
| DII | 1.15 | 2.36 | 1.39 | 0.63 | 0.39 | 0.51 | 0.19 | 0.61 | 0.58 | 0.83 |
| Public | 36.16 | 36.16 | 36.16 | 36.16 | 36.16 | 36.16 | 36.16 | 36.16 | 36.16 | 36.16 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 14.64 | 29.28 | 29.28 | 29.28 | 29.28 | 29.28 | 29.28 | 29.28 | 29.28 | 29.28 |
| FII | 0.94 | 1.94 | 1.94 | 0.91 | 0.86 | 0.93 | 0.99 | 0.94 | 0.74 | 1 |
| DII | 0.26 | 1.08 | 0.64 | 0.29 | 0.18 | 0.24 | 0.09 | 0.28 | 0.27 | 0.38 |
| Public | 8.29 | 16.58 | 16.58 | 16.58 | 16.58 | 16.58 | 16.58 | 16.58 | 16.58 | 16.58 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22.93 | 45.87 | 45.87 | 45.87 | 45.87 | 45.87 | 45.87 | 45.87 | 45.87 | 45.87 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.